Talis Biomedical (TLIS) Institutional Ownership $1.41 +0.16 (+12.80%) As of 07/24/2025 09:42 AM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Talis Biomedical (NASDAQ:TLIS)CurrentInstitutional OwnershipPercentage43.77%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$381.02KNumber ofInstitutional Sellers(last 12 months)0 Get TLIS Insider Trade Alerts Want to know when executives and insiders are buying or selling Talis Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TLIS Institutional Buying and Selling by Quarter Talis Biomedical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/5/2024BML Capital Management LLC248,702$460K0.3%+481.9%13.665% 1/30/2024BML Capital Management LLC42,743$318K0.2%N/A2.349% 12/6/2023Citigroup Inc.5,267$30K0.0%N/A0.289% 5/17/2022Greenlight Capital Inc.2,235,783$3.15M0.2%+42.5%8.399% 5/9/2022Qube Research & Technologies Ltd47,467$67K0.0%-19.8%0.178% 2/14/2022Greenlight Capital Inc.1,569,300$6.29M0.4%N/A5.969% 2/10/2022Qube Research & Technologies Ltd59,161$237K0.0%+153.9%0.225% 2/4/2022Mercer Global Advisors Inc. ADV11,035$44K0.0%-44.9%0.042% 2/1/2022Qube Research & Technologies Ltd59,161$237K0.0%+153.9%0.225% 11/18/2021Personal CFO Solutions LLC17,000$106K0.0%N/A0.065% Get the Latest News and Ratings for TLIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Talis Biomedical and its competitors with MarketBeat's FREE daily newsletter. 11/17/2021ArrowMark Colorado Holdings LLC5,893,876$36.84M0.3%+0.4%22.420% 11/12/2021Geode Capital Management LLC302,968$1.89M0.0%+17.4%1.179% 11/9/2021BlackRock Inc.813,137$5.08M0.0%+0.7%3.165% 11/4/2021Deutsche Bank AG15,007$94K0.0%+85.9%0.058% 9/3/2021Parametric Portfolio Associates LLC50,496$557K0.0%+21.3%0.197% 8/25/2021Marshall Wace LLP11,326$125K0.0%-80.2%0.044% 8/17/2021ArrowMark Colorado Holdings LLC5,871,925$32.69M0.2%-2.2%22.856% 8/16/2021Cubist Systematic Strategies LLC22,920$253K0.0%N/A0.089% 8/16/2021Redmile Group LLC363,849$4.01M0.1%-9.0%1.416% 8/16/2021Alyeska Investment Group L.P.100,000$1.10M0.0%+100.0%0.389% 8/16/2021Morgan Stanley442,250$4.88M0.0%+2,458.6%1.721% 8/16/2021Charles Schwab Investment Management Inc.95,996$1.06M0.0%+2.5%0.374% 8/16/2021State Street Corp205,925$2.27M0.0%+40.0%0.802% 8/16/2021Nuveen Asset Management LLC40,060$442K0.0%+87.1%0.156% 8/16/2021Federated Hermes Inc.15,000$165K0.0%-98.5%0.058% 8/16/2021Marshall Wace LLP11,326$125K0.0%-80.2%0.044% 8/13/2021Geode Capital Management LLC258,043$2.85M0.0%+11.2%1.006% 8/13/2021Vanguard Group Inc.544,906$6.01M0.0%+39.7%2.125% 8/12/2021JPMorgan Chase & Co.42,230$466K0.0%-73.4%0.165% 8/11/2021Bank of New York Mellon Corp84,983$938K0.0%+6.3%0.331% 8/11/2021BlackRock Inc.807,299$8.90M0.0%+11.8%3.149% 8/10/2021Nicholas Investment Partners LP1,071,315$11.82M0.7%-2.7%4.179% 8/5/2021Legato Capital Management LLC18,585$205K0.0%N/A0.072% 8/5/2021Capital Analysts LLC3,600$40K0.0%N/A0.014% 8/5/2021Rhumbline Advisers12,976$143K0.0%N/A0.051% 8/2/2021New York State Common Retirement Fund38,414$424K0.0%-2.9%0.150% 5/18/2021Tudor Investment Corp Et Al10,000$129K0.0%N/A0.039% 5/18/2021California State Teachers Retirement System19,965$257K0.0%N/A0.078% 5/17/2021Nuveen Asset Management LLC21,415$275K0.0%N/A0.084% 5/13/2021Bank of New York Mellon Corp79,941$1.03M0.0%N/A0.312% Critical AI announcement set to ignite AI 2.0 (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.5/12/2021Northern Trust Corp138,481$1.78M0.0%N/A0.540% 5/12/2021UBS Group AG3,211$41K0.0%N/A0.013% (Data available from 1/1/2016 forward) TLIS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TLIS shares? During the previous two years, the following institutional investors and hedge funds held shares of Talis Biomedical shares: BML Capital Management LLC ($460K), Citigroup Inc. ($30K).Learn more on Talis Biomedical's institutional investors. What percentage of Talis Biomedical's stock is owned by institutional investors? 43.77% of Talis Biomedical's stock is owned by institutional investors. Learn more on TLIS's institutional investor holdings. Which institutional investors have been buying Talis Biomedical's stock? The following institutional investors have purchased Talis Biomedical's stock in the last 24 months: BML Capital Management LLC ($248.70K), and Citigroup Inc. ($5.27K). How much institutional buying is happening at Talis Biomedical? Institutional investors have bought a total of 205,959 shares in the last 24 months. This purchase volume represents approximately $381.02K in transactions. Related Companies TT Major Shareholders KEYS Major Shareholders VLTO Major Shareholders FTV Major Shareholders TER Major Shareholders RVTY Major Shareholders AVTR Major Shareholders NVMI Major Shareholders VNT Major Shareholders RAL Major Shareholders This page (NASDAQ:TLIS) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talis Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
